James Cass is an accomplished professional in the field of microbiology and environmental science, currently serving as the Director of Molecular & Viral Safety at Merck since July 2023. Prior experience includes a tenure as the Director of Phage Discovery at The Janssen Pharmaceutical Companies of Johnson & Johnson from June 2022 to May 2023 and various roles at Phico Therapeutics Ltd. from November 2012 to June 2022, including R&D Director, R&D Manager, and Microbiology Manager. Earlier career stages involved positions such as Postdoctoral Research Fellow at the University of the Western Cape and Post Doctoral Research Scientist at Biocontrol Ltd. James Cass holds a Doctor of Philosophy (PhD) in Environmental Science/Microbiology from Imperial College London and a Bachelor of Science (BS) in Biology/Biological Sciences from the University of Plymouth.
This person is not in any teams
This person is not in any offices